The Advisory Board is a non-executive board whose task is to ensure the proper functioning of the company and to report to shareholders. It is composed of independent experts and key shareholders.

Dr Nicolas Foray

PhD, co-founder

Radiobiologist, author of more than 70 publications

Scientific affairs

 

 

Pr Éric Lartigau

Independant Expert

CEO of Centre Oscar Lambret (Lille, France), Radiation Oncologist, University Medical Professor in Oncology

Advisor in medical Affairs

 

 

Pr Michel Bourguignon

Independant Expert

MD, PhD, Board Advisor at IRSN/Technical Expert for ICRP/AIEA/EURATOM, Former Commissioner of ASN

Advisor in Nuclear medicine

 

 

Viviane Neiter

Shareholder

Administrator of several Listed and non Listed Company worldwide

Advisor in Governance

 

 

Yann Godfrin

Independant Expert

PhD, Founder and former CEO of Erytech Pharma; CEO of Neuronax, President; Hemosystem (kit diagnostic)

Advisor in Corporate affairs

 

Last news

Radiosensitivity on a Blood test

Radiosensitivity on a Blood test  July 2017 After intense R&D, Neolys Diagnostics is proud to announce that our R...

BIO2017 – San Diego

BIO2017 – San Diego June 2017 Seeking for sound industrial partners at in North America and Asia, Neolys Diagnostics...

ESTRO 2017 - Vienna

ESTRO 2017 - Vienna May 2017 During the ESTRO (European Society for Radiotherapy and Oncology) Congress in Vienna, Dr ...

All news

Our Technology

Our technology is the result of over ten years of research by the Radiobiology Group. Their work on individual sensitivity have allowed to set up predictive tests. This technology offers a promissing solution, optimizing the efficiency of radiotherapy treatments and preventing toxicity at the same time.

Read more +